Global antimicrobial resistance and use surveillance system (GLASS 2022): Investigating the relationship between antimicrobial resistance and antimicrobial consumption data across the participating countries.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2024
2024
Historique:
received:
09
10
2023
accepted:
14
01
2024
medline:
5
2
2024
pubmed:
5
2
2024
entrez:
5
2
2024
Statut:
epublish
Résumé
For the first time since 2015, the World Health Organization's (WHO) global Antimicrobial Resistance and Use Surveillance (GLASS) featured both global reports for antimicrobial resistance (AMR) and antimicrobial consumption (AMC) data in its annual reports. In this study we investigated the relationship of AMR with AMC within participating countries reported in the GLASS 2022 report. Our analysis found a statistically significant correlation between beta-lactam/cephalosporin and fluoroquinolones consumption and AMR to these antimicrobials associated with bloodstream E. coli and Klebsiella pneumoniae among the participating countries (P<0.05). We observed that for every 1 unit increase in defined daily dose DDD of beta-lactam/cephalosporins and quinolone consumptions among the countries, increased the recoveries of bloodstream-associated beta-lactam/cephalosporins-resistant E. coli/Klebsiella spp. by 11-22% and quinolone-resistant E. coli/Klebsiella spp. by 31-40%. When we compared the antimicrobial consumptions between the antimicrobial ATC (Alphanumeric codes developed by WHO) groups and countries, we observed a statistically significant higher daily consumption of beta-lactam-penicillins (J01C, DDD difference range: 5.23-8.13) and cephalosporins (J01D, DDD difference range: 2.57-5.13) compared to other antimicrobial groups among the countries (adjusted for multiple comparisons using Tukey's method). Between the participating countries, we observed a statistically significant higher daily consumption of antimicrobial groups in Iran (DDD difference range: 3.63-4.84) and Uganda (DDD difference range: 3.79-5.01) compared to other participating countries (adjusted for multiple comparisons using Tukey's method). Understanding AMC and how it relates to AMR at the global scale is critical in the global AMR policy development and implementation of global antimicrobial stewardship.
Identifiants
pubmed: 38315668
doi: 10.1371/journal.pone.0297921
pii: PONE-D-23-32918
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0297921Informations de copyright
Copyright: © 2024 Ajulo, Awosile. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Déclaration de conflit d'intérêts
The authors do not have any conflict of interest.
Références
Clin Ther. 2002 Jan;24(1):197-204
pubmed: 11833832
Lancet. 2022 Feb 12;399(10325):629-655
pubmed: 35065702
Lancet Infect Dis. 2011 Sep;11(9):692-701
pubmed: 21659004
Can J Vet Res. 2008;72(2):181-7
pubmed: 18505208
Int J Infect Dis. 2017 Apr;57:3-12
pubmed: 28111172
Euro Surveill. 2018 Nov;23(46):
pubmed: 30458912
Lancet Infect Dis. 2016 Jul;16(7):775
pubmed: 27352753
Vet World. 2022 Mar;15(3):743-749
pubmed: 35497962
Proc Biol Sci. 2018 Apr 11;285(1876):
pubmed: 29643217
F1000Res. 2019 Mar 1;8:238
pubmed: 30906539
Am J Manag Care. 2015 Oct 01;21(10):e567-75
pubmed: 26619058
Antibiotics (Basel). 2015 Oct 30;4(4):467-79
pubmed: 27025636
Foodborne Pathog Dis. 2011 Dec;8(12):1295-301
pubmed: 21883007
Lancet Infect Dis. 2018 Dec;18(12):e368-e378
pubmed: 30172580
APMIS. 1998 Aug;106(8):745-70
pubmed: 9744762
Bull World Health Organ. 2023 Jun 1;101(6):403-411
pubmed: 37265674
EXCLI J. 2013 May 07;12:384-95
pubmed: 26622211
Travel Med Infect Dis. 2020 Mar - Apr;34:101548
pubmed: 31870880
Infect Dis Ther. 2015 Sep;4(Suppl 1):51-64
pubmed: 26362295
Ther Adv Infect Dis. 2016 Feb;3(1):15-21
pubmed: 26862399
Antibiotics (Basel). 2020 Nov 07;9(11):
pubmed: 33171743
J Clin Diagn Res. 2013 Jun;7(6):1207-14
pubmed: 23905143
Saudi J Biol Sci. 2017 May;24(4):808-812
pubmed: 28490950
J Prim Care Community Health. 2020 Jan-Dec;11:2150132720961255
pubmed: 32996372
Curr Opin Infect Dis. 2021 Oct 1;34(5):423-431
pubmed: 34267046
Antimicrob Resist Infect Control. 2018 Apr 25;7:56
pubmed: 29736236
BMJ Glob Health. 2019 Nov 10;4(6):e002104
pubmed: 31799007
J Clin Med. 2019 Nov 17;8(11):
pubmed: 31744181
Surg Infect (Larchmt). 2020 Sep;21(7):579-585
pubmed: 32434446
JAMA. 2016 May 3;315(17):1864-73
pubmed: 27139059
Lancet Infect Dis. 2005 Aug;5(8):481-93
pubmed: 16048717
Clin Infect Dis. 2015 Mar 15;60(6):837-46
pubmed: 25613287
Clin Infect Dis. 2015 Feb 1;60(3):439-52
pubmed: 25301206
Antibiotics (Basel). 2021 May 03;10(5):
pubmed: 34063697
Lancet Infect Dis. 2019 Dec;19(12):1345-1354
pubmed: 31588042
Med Sci (Basel). 2017 Dec 21;6(1):
pubmed: 29267233
Biomed Res Int. 2022 Jun 6;2022:1668789
pubmed: 35707374
Clin Infect Dis. 2014 Sep 15;59 Suppl 2:S71-5
pubmed: 25151481
Clin Infect Dis. 2016 Oct 15;63(8):1087-1093
pubmed: 27439526
Lancet Reg Health Eur. 2022 Dec 22;26:100563
pubmed: 36895445
J Glob Infect Dis. 2018 Oct-Dec;10(4):212-217
pubmed: 30581263
J Glob Infect Dis. 2019 Jan-Mar;11(1):36-42
pubmed: 30814834
Clin Infect Dis. 2021 Jan 29;72(Suppl 1):S17-S26
pubmed: 33512523
Clin Microbiol Infect. 2017 Nov;23(11):793-798
pubmed: 28882725
Lancet Infect Dis. 2015 May;15(5):581-614
pubmed: 25932591
Microbiol Mol Biol Rev. 2010 Sep;74(3):417-33
pubmed: 20805405
J Travel Med. 2019 Dec 23;26(8):
pubmed: 31115466
Int J Antimicrob Agents. 2017 Sep;50(3):441-446
pubmed: 28668688
J Glob Antimicrob Resist. 2020 Dec;23:430-438
pubmed: 33176216
CMAJ. 2017 Jan 9;189(1):E2-E3
pubmed: 28246252
BMJ Glob Health. 2017 Oct 31;2(4):e000518
pubmed: 29225955
Int J Antimicrob Agents. 2018 Dec;52(6):771-782
pubmed: 30312654
Lancet. 2016 Jan 9;387(10014):176-87
pubmed: 26603922
Med Mal Infect. 2010 Jun;40(6):333-40
pubmed: 19951830
IJID Reg. 2021 Oct 02;1:65-71
pubmed: 35757828
Clin Microbiol Infect. 2016 May;22(5):408-15
pubmed: 27021418
Proc Natl Acad Sci U S A. 2015 May 5;112(18):5649-54
pubmed: 25792457
J Infect Chemother. 2020 Sep;26(9):955-958
pubmed: 32446727
P T. 2015 Apr;40(4):277-83
pubmed: 25859123
J Infect. 2017 Feb;74(2):131-141
pubmed: 27838521
Lancet Infect Dis. 2018 Mar;18(3):e99-e106
pubmed: 29102325
Lancet Glob Health. 2021 May;9(5):e610-e619
pubmed: 33713630
Lancet Glob Health. 2021 May;9(5):e561-e562
pubmed: 33713631
Clin Infect Dis. 2018 Mar 5;66(6):963-969
pubmed: 29346620
Proc Natl Acad Sci U S A. 2018 Aug 28;115(35):E8109-E8110
pubmed: 30087189
Clin Microbiol Infect. 2009 Apr;15 Suppl 3:12-5
pubmed: 19366364
Antibiotics (Basel). 2020 Oct 30;9(11):
pubmed: 33143207
J Clin Pharm Ther. 2018 Oct;43(5):606-613
pubmed: 29959783
J Antimicrob Chemother. 2014 Mar;69(3):827-34
pubmed: 24216767
Cureus. 2018 Apr 5;10(4):e2428
pubmed: 29876150
J Hosp Infect. 2019 Apr;101(4):426-427
pubmed: 30826342
Br J Gen Pract. 2014 Dec;64(629):604-5
pubmed: 25452508
Int J Environ Res Public Health. 2011 Aug;8(8):3246-62
pubmed: 21909304
Antibiotics (Basel). 2020 Jul 01;9(7):
pubmed: 32630353
Infect Drug Resist. 2019 Dec 20;12:3903-3910
pubmed: 31908502